StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report released on Monday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Up 31.5 %
Shares of NYSE AMPE opened at $0.33 on Monday. The firm’s fifty day moving average is $1.11 and its 200 day moving average is $1.82. Ampio Pharmaceuticals has a 52 week low of $0.14 and a 52 week high of $8.30. The company has a market cap of $376,200.00, a price-to-earnings ratio of -0.03 and a beta of 1.95.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last issued its quarterly earnings data on Wednesday, March 27th. The company reported ($2.48) EPS for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- AMD is Down 35%. Now is the Time to Buy the Dip
- What is a Special Dividend?
- Amazon Stands Tall: New Highs Are in Sight
- The How and Why of Investing in Gold Stocks
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
